Genetic susceptibility and resistance to influenza infection and disease in humans and mice

References

• Tam JS. Influenza A (H5N1) in Hong Kong: an overview. Vaccine20(Suppl. 2), S77–S81 (2002).
   Google Scholar
• Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev.20, 243–267 (2007).
   PubMed Web of Science ®Google Scholar
• Shortridge KF, Peiris JS, Guan Y. The next influenza pandemic: lessons from Hong Kong. J. Appl. Microbiol.94(Suppl.), 70S–79S (2003).
   PubMedGoogle Scholar
• Sims LD, Ellis TM, Liu KK et al. Avian influenza in Hong Kong 1997–2002. Avian Dis.47(Suppl. 3), 832–838 (2003).
   PubMed Web of Science ®Google Scholar
• Johnson NPAS, Mueller J. Updating the accounts: global mortality in the 1918–1920 “Spanish” influenza pandemic. Bull. Hist. Med.76, 105–115 (2002).
   PubMed Web of Science ®Google Scholar
• Oxford JS. Influenza A pandemics of the 20th Century with special reference to 1918: virology, pathology and epidemiology. Rev. Med. Virol.10, 119–133 (2000).
   PubMed Web of Science ®Google Scholar
• Bridges CB, Lim W, Hu-Primmer J et al. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997–1998. J. Infect. Dis.185, 1005–1010 (2005).
   Google Scholar
• Hinjoy S, Puthavathana P, Laosititaworm Y et al. Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Emerg. Infect. Dis.14, 499–501 (2008).
   PubMed Web of Science ®Google Scholar
• Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. Morbid. Mortal. Weekly Rep.50(RR-4), 1–44 (2001).
   PubMedGoogle Scholar
• De Maio A, Torres MB, Reeves RH. Genetic determinants influencing the response to injury, inflammation, and sepsis. Shock23(1), 11–17 (2005).
   PubMed Web of Science ®Google Scholar
• Hill AVS. The genomics and genetics of human infectious disease susceptibility. Ann. Rev. Genomics Hum. Genet.2, 373–400 (2001).
   PubMedGoogle Scholar
• Sorensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med.318, 727–732 (1988).
   PubMed Web of Science ®Google Scholar
• Tuite A, Gros P. The impact of genomics on analysis of host resistance to infectious disease. Microb. Infect.8, 1647–1653 (2006).
   PubMed Web of Science ®Google Scholar
• Dinh PN, Long HT, Tien NT et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg. Infect. Dis.12, 1841–1847 (2006).
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Ungchusak K, Sovann L et al. Family clustering of avian influenza A (H5N1). Emerg. Infect. Dis.11, 1799–1801 (2005).
   PubMed Web of Science ®Google Scholar
• Normile D. Indonesia taps village wisdom to fight bird flu. Science315, 30–33 (2007).
   PubMed Web of Science ®Google Scholar
• Pitzer VE, Olsen SJ, Bergstrom CT, Dowell SF, Lipsitch M. Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg. Infect. Dis.13, 1074–1076 (2007).
   PubMedGoogle Scholar
• Beigel JH, Farrar J, Han AM et al. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med.353, 1374–1385 (2005).
   PubMed Web of Science ®Google Scholar
• Perdue ML, Swayne DE. Public health risk from avian influenza viruses. Avian Dis.49, 317–327 (2005).
   PubMed Web of Science ®Google Scholar
• Suzuki Y. Sialobiology of influenza: molecular mechanisms of host range variation of influenza viruses. Biol. Pharm. Bull.28, 399–408 (2005).
   PubMed Web of Science ®Google Scholar
• Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu influenza virus receptors in the human airway. Nature440, 435–436 (2006).
   PubMed Web of Science ®Google Scholar
• Rumyantsev SN. Genetic immunity and influenza pandemic. FEMS Immunol. Med. Microbiol.48, 1–10 (2006).
   PubMedGoogle Scholar
• Glaser L, Stevens J, Zamarin D et al. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol.79, 11533–11536 (2005).
   PubMed Web of Science ®Google Scholar
• Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science312, 404–410 (2006).
   PubMed Web of Science ®Google Scholar
• van Riel D, Munster VJ, de Wit E et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol.171(4), 1215–1223 (2007).
   PubMed Web of Science ®Google Scholar
• van Riel D, Munster VJ, de Wit E, Rimmelzwann GF, Fouchier RA, Osterhaus AD et al. H5N1 virus attachment to lower respiratory tract. Science312, 399 (2006).
   PubMed Web of Science ®Google Scholar
• Toth LA, Rehg JE, Webster RG. Strain differences in sleep and other pathophysiological sequelae of influenza virus infection in naive and immunized mice. J. Neuroimmunol.58, 89–99 (1995).
   PubMedGoogle Scholar
• Leung KN, Ada GL. Induction of natural killer cells during murine influenza virus infection. Immunobiology160, 352–366 (1981).
   PubMedGoogle Scholar
• Stein-Streilein J, Bennett M, Mann D, Kumar V. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J. Immunol.131, 2699–2704 (1983).
   PubMed Web of Science ®Google Scholar
• Stein-Streilein J, Guffee J. in vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J. Immunol.136, 1435–1441 (1986).
   PubMed Web of Science ®Google Scholar
• Wyde PR, Wilson MR, Cate TR. Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection. Infect. Immun.38, 1249–1255 (1982).
   PubMed Web of Science ®Google Scholar
• Allan W, Zsuzsanna T, Cleary A, Doherty PC. Cellular events in the lymph node and lung of mice with influenza. J. Immunol.144, 3980–3986 (1990).
   PubMedGoogle Scholar
• Wyde PR, Cate TR. Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses. Infect. Immun.22, 423–429 (1978).
   PubMed Web of Science ®Google Scholar
• Thepen T, Hoeben K, Breve J, Kraal G. Alveolar macrophages down-regulate local pulmonary immune responses against intratracheally administered T-cell-dependent, but not T-cell-independent antigens. Immunology76, 60–64 (1992).
   PubMedGoogle Scholar
• Thepen T, van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med.170, 499–509 (1989).
   PubMed Web of Science ®Google Scholar
• Ding M, Lu L, Toth LA. Gene expression in lung and basal forebrain during influenza infection in mice. Genes Brain Behav.7(2), 173–183 (2008).
   PubMedGoogle Scholar
• Toth LA, Verhulst SJ. Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behav. Genet.33, 325–336 (2003).
   PubMedGoogle Scholar
• Kash JC, Basler CF, Garcia-Sastre DE et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J. Virol.78, 9499–9511 (2004).
   PubMedGoogle Scholar
• Kash JC, Tumpey TM, Proll SC et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature443, 578–581 (2006).
   PubMed Web of Science ®Google Scholar
• Chen H, Sharp BM. Content-rich biological network constructed by mining PubMed abstracts. BMC Bioinformatics5, 147–160 (2004).
   PubMedGoogle Scholar
• Hayashi S, Jibiki I, Asai Y et al. Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activted protein kinase and c-Jun-N-terminal kinase. Respirology13, 203–214 (2008).
   PubMedGoogle Scholar
• De Maeyer E, De Maeyer-Guignard J. A gene with quantitative effect on circulating interferon induction – further studies. Ann. NY Acad. Sci.173, 228–238 (1970).
   Google Scholar
• Shirahata T, Mori A, Ishikawa H, Goto H. Strain differences of interferon-generating capacity and resistance in toxoplasma-infected mice. Microbiol. Immunol.30, 1307–1316 (1986).
   PubMedGoogle Scholar
• Tyring SK, Lefkowitz SS. Strain differences in production of murine interferons. Proc. Soc. Exp. Biol. Med.164, 519–523 (1980).
   PubMedGoogle Scholar
• Toth LA. Strain differences in the somnogenic effects of interferon inducers in mice. J. Interferon Cytokine Res.16, 1065–1072 (1996).
   PubMedGoogle Scholar
• Gariglio M, Panico S, Cavallo G, Divaker C, Lengyel P, Landolfo S. Impaired transcription of the poly rI:C- and interferon-activatable 202 gene in mice and cell lines from the C57BL/6 strain. Virology187, 115–123 (1992).
   PubMedGoogle Scholar
• Lindenmann J. Resistance of mice to mouse adapted influenza a virus. Virology16, 203 (1962).
   PubMedGoogle Scholar
• Pavlovic J, Zurcher T, Haller O et al. Resistance to influenza virus and vesicular stomatitis virus confirmed by expression of human MxA protein. J. Virol.643370–3375 (1990).
   PubMed Web of Science ®Google Scholar
• Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell Biol.45, 18–23 (1988).
   Google Scholar
• Haller O, Staeheli P, Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie89, 812–818 (2007).
   PubMed Web of Science ®Google Scholar
• Vanlaere I, Vanderrijst A, Guenet JL, De Filette M, Libert C. Mx1 causes resistance against influenza A viruses in the Mus spretus-derived inbred mouse strain SPRET/Ei. Cytokine42, 72–70 (2008).
   Google Scholar
• Pavlovic J, Haller O, Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol.66, 2564–2569 (1992).
   PubMed Web of Science ®Google Scholar
• Nakajima E, Morozumi T, Tsukamoto K, Watanabe T, Plastow G, Mitsuhashi T. A naturally occurring variant of porcine Mx1 associated with increased susceptibility to influenza virus in vitro. Biochem. Genet.45, 11–24 (2007).
   PubMed Web of Science ®Google Scholar
• Palm M, Leroy A, Thomas A, Linden A, Desmecht D. Differential anti-influenza activity among allelic variants at the Sus scrofa Mx1 locus. J. Interferon Cytokine Res.27, 147–155 (2007).
   PubMedGoogle Scholar
• Seyama T, Ko JH, Ohe M et al. Population research of genetic polymorphism at amino acid position 631 in chicken Mx protein with differential antiviral activity. Biochem. Genet.44, 437–448 (2006).
   PubMedGoogle Scholar
• Colina R, Costa-Mattiolo M, Dowling RJO et al. Translational control of the innate immune response through IRF-7. Nature452, 323–328 (2008).
   PubMed Web of Science ®Google Scholar
• Chomik M. Interferon induction by influenza virus: significance of neuraminidase. Arch. Immunol. Ther. Exp.29, 109–114 (1981).
   PubMedGoogle Scholar
• Dittmann J, Stertz S, Grimm D et al. Influenza A virus strains differ in sensitivity to the antiviral action of the Mx-GTPase. J. Virol.82(7), 3624–3631 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative strand RNA viruses. Virology279, 375–384 (2001).
   PubMedGoogle Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med.354(6), 610–621 (2006).
   PubMed Web of Science ®Google Scholar
• Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol.22, 891–928 (2004).
   PubMed Web of Science ®Google Scholar
• Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol.2(2), 123–128 (2001).
   PubMed Web of Science ®Google Scholar
• Moyron-Quiroz J, Rangel-Moreno J, Carragher DM, Randall TD. The function of local lymphoid tissues in pulmonary immune responses. Adv. Exp. Med. Biol.590, 55–68 (2007).
   PubMed Web of Science ®Google Scholar
• Serra HM, Baena-Cagnani CE, Eberhard Y. Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine? Allergy59(11), 1219–1223 (2004).
   PubMedGoogle Scholar
• Mueller SN, Hosiawa-Meager KA, Korniczny BT et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science317, 670–674 (2007).
   PubMedGoogle Scholar
• Moyron-Quiroz JE, Rangel-Moreno J, Kusser K et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med.10, 927–934 (2004).
   PubMed Web of Science ®Google Scholar
• Aust G, Sittig D, Becherer L et al. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur. J. Endocrinol.150(2), 225–234 (2004).
   PubMed Web of Science ®Google Scholar
• Hjelmstrom P, Fjell J, Nakagawa T, Sacca R, Cuff CA, Ruddle NH. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol.156(4), 1133–1138 (2000).
   PubMed Web of Science ®Google Scholar
• Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest.116(12), 3183–3194 (2006).
   PubMed Web of Science ®Google Scholar
• Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1α for an inflammatory response to viral infection. Science269, 1583–1585 (1995).
   PubMed Web of Science ®Google Scholar
• Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza virus. Am. J. Pathol.156, 1951–1959 (2000).
   PubMed Web of Science ®Google Scholar
• Dessing MC, van der Sluijs KF, Florquin S, van der Poll T. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin. Immunol.125(3), 328–336 (2007).
   PubMed Web of Science ®Google Scholar
• Sladkova T, Kostolansky F. The role of cytokines in the immune response to influenza A virus infection. Acta Virol.50(3), 151–162 (2006).
   PubMedGoogle Scholar
• Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR. Chemokine expression during development and resolution of a pulmonary leukocyte response to infleunza A virus infection in mice. J. Leukoc. Biol.76, 886–895 (2004).
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Wei T, Janson PC et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS ONE2(7), E610 (2007).
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity26(2), 133–137 (2007).
   PubMed Web of Science ®Google Scholar
• Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene25(46), 6163–6169 (2006).
   PubMed Web of Science ®Google Scholar
• Asirvatham AJ, Gregorie CJ, Hu Z, Mahner WJ, Tomasi TB. MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components. Molec. Immunol.45(7), 1995–2006 (2007).
   PubMedGoogle Scholar
• Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin. Cancer Biol.18(2), 131–140 (2007).
   Google Scholar
• O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA104(5), 1604–1609 (2007).
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Vigorito E, Clare S et al. Requirement of bic/microRNA-155 for normal immune function. Science316(5824), 608–611 (2007).
   PubMed Web of Science ®Google Scholar
• Hsu HC, Lu L, Yi N, Van Zant G, Williams RW, Mountz JD. Quantitative trait locus (QTL) mapping in aging systems. Methods Mol. Biol.371, 321–348 (2007).
   PubMedGoogle Scholar
• Carthew RW. Gene regulation by microRNAs. Curr. Opin. Genet. Dev.16(2), 203–208 (2006).
   PubMed Web of Science ®Google Scholar
• Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol. Cell26(5), 753–767 (2007).
   PubMed Web of Science ®Google Scholar
• Lu B, Rutledge BJ, Gu L et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med.187, 601–608 (1998).
   PubMed Web of Science ®Google Scholar
• Toth LA, Hughes LF. Macrophage participation in influenza-induced sleep enhancement in C57BL/6J mice. Brain Behav. Immun.18, 375–389 (2004).
   PubMedGoogle Scholar
• Fincher EF, Johannsen L, Kapás L, Takahashi S, Krueger JM. Microglia digest Staphylococcus aureus into low molecular weight biologically active compounds. Am. J. Physiol.271, R149–R156 (1996).
   Google Scholar
• Johannsen L, Rosenthal RS, Martin SA et al. Somnogenic activity of O-acetylated and dimeric muramyl peptides. Infect. Immun.57, 2726–2732 (1989).
   PubMedGoogle Scholar
• Asanuma H, Hirokawa K, Uchiyama M et al. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Vaccine19, 3981–3989 (2001).
   PubMed Web of Science ®Google Scholar
• Hocart MJ, Mackenzie JS, Stewart GA. The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies. J. Gen. Virol.70(Pt. 9), 2439–2448 (1989).
   PubMedGoogle Scholar
• Yuen KY, Chan PK, Peiris JS et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1. Lancet351, 467–471 (1998).
   PubMed Web of Science ®Google Scholar
• Peiris JS, Yu WC, Leung CW et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet363, 617–619 (2004).
   PubMed Web of Science ®Google Scholar
• Cheung CY, Poon LL, Lau AS et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet360, 1831–1837 (2002).
   PubMed Web of Science ®Google Scholar
• de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Med.12, 1203–1207 (2006).
   PubMed Web of Science ®Google Scholar
• Fritz RS, Hayden FG, Calfee DP et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J. Infect. Dis.180, 586–593 (1999).
   PubMed Web of Science ®Google Scholar
• Hayden FG, Fritz RS, Lobo MC, Alvord WG, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J. Clin. Invest.101, 643–649 (1998).
   PubMed Web of Science ®Google Scholar
• Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. Symptom pathogenesis during acute influenza: interluekin-6 and other cytokine responses. J. Med. Virol.64, 262–268 (2001).
   PubMed Web of Science ®Google Scholar
• Albright FA, Orlando P, Pavia AT, Jackson GG, Albright LAC. Evidence for a heritable predisposition to death due to influenza. J. Infect. Dis.197, 1–7 (2008).
   PubMedGoogle Scholar
• Gottfredsson M, Jonsson S, Kristjansson M et al. Lessons from the past: familial aggregation analysis of fatal pandemic influenza (Spanish flu) in Iceland in 1918. Proc. Natl Acad. Sci. USA105, 1303–1308 (2008).
   PubMedGoogle Scholar
• Douglas SD. Down syndrome: immunologic and epidemiologic associations – engimas remain. J. Pediatr.147, 723–725 (2005).
   PubMedGoogle Scholar
• Gerdes AM, Horder M, Bonnevie-Nielsen V. Increased IFN-α-induced sensitivity but reduced reactivity of 2´.5´-oligoadenylate synthase (2,5AS) in trisomy 21 blood lymphocytes. Clin. Exp. Immunol.93, 93–96 (1993).
   PubMedGoogle Scholar
• Gerdes AM, Horder M, Petersen PH, Bonnevie-Nielsen V. Effect of increased gene dosage expression on the α-interferon receptors in Down’s syndrome. Biochim. Biophys. Acta1181, 135–140 (1993).
   PubMed Web of Science ®Google Scholar
• Nurmi T, Huffunen K, Lassila O et al. Natural killer cell function in trisomy-21 (Down’s syndrome). Clin. Exp. Immunol.47, 735–741 (1982).
   PubMedGoogle Scholar
• Horisberger MA. Interferons, Mx genes, and resistance to influenza viruses. Am. J. Respir. Crit. Care Med.152(4 Pt 2), S67–S71 (1995).
   PubMed Web of Science ®Google Scholar
• Fontana S, Moratto D, Mangal S et al. Functional defects of dendritic cells in patients with CD40 deficiencies. Blood102, 4099–4106 (2003).
   PubMed Web of Science ®Google Scholar
• Levin S, Hahn T. Interferon deficiency syndrome. Clin. Exp. Immunol.60, 267–273 (1985).
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptor signaling. J. Biol. Chem.278(40), 38105–38108 (2003).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388(6640), 394–397 (1997).
   PubMed Web of Science ®Google Scholar
• Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis.5(3), 156–164 (2005).
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature413(6857), 732–738 (2001).
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa S. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science303(5663), 1529–1531 (2004).
   PubMed Web of Science ®Google Scholar
• Osterlund P, Weckman V, Siren J et al. Gene expression and antiviral activity of α/β interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol.79, 9608–9617 (2005).
   PubMedGoogle Scholar
• Guillot L, Le Goffic R, Bloch S et al. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem.280(7), 5571–5580 (2005).
   PubMed Web of Science ®Google Scholar
• Ichiyama T, Morishima T, Isumi H, Matsufuji H, Matsubara T, Furukawa S. Analysis of cytokine levels and NF-κB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy. Cytokine27, 31–37 (2004).
   PubMed Web of Science ®Google Scholar
• Nunoi H, Mercado T, Mizukami T et al. Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr. Int.47, 175–179 (2005).
   PubMed Web of Science ®Google Scholar
• Hidaka F, Matsuo S, Muta T, Takeshiga K, Mizukami T, Nunoi H. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin. Immunol.119, 188–194 (2006).
   PubMed Web of Science ®Google Scholar
• Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain–Barre syndrome and the 1978–1979 influenza vaccine. N. Engl. J. Med.304, 1557–1561 (1981).
   PubMed Web of Science ®Google Scholar
• Tang YW, Li H, We H, Shyr Y, Edwards KM. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J. Infect. Dis.196, 1021–1025 (2007).
   PubMedGoogle Scholar
• Gelder CM, Lambkin R, Hart KW et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. J. Infect. Dis.185, 114–117 (2002).
   PubMed Web of Science ®Google Scholar
• Gomi K, Tokue Y, Kobayashi T et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest126(1), 95–99 (2004).
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet.24(1), 1–8 (1997).
   PubMedGoogle Scholar
• Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10–1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med.32(2), 260–266 (2006).
   PubMed Web of Science ®Google Scholar
• Gallagher PM, Lowe G, Fitzgerald T et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax58(2), 154–156 (2003).
   PubMed Web of Science ®Google Scholar
• Van Loveren H, Van Amsterdam JG, Vandebriel RJ et al. Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ. Health Perspect.109(8), 757–764 (2001).
   PubMed Web of Science ®Google Scholar
• Lambkin R, Novelli P, Oxford J, Gelder C. Human genetics and responses to influenza vaccination. Am. J. Pharmacogenomics4, 293–298 (2004).
   PubMedGoogle Scholar
• Fazekas de St.Groth S, Webster RG. Disquisitions of original antigenic sin: I. Evidence in man. J. Exp. Med.124, 331–345 (1966).
   PubMed Web of Science ®Google Scholar
• Fazekas de St.Groth B, Webster RG. Disquisition on original antigenic sin: II. Proof in lower creatures. J. Exp. Med.124, 347–361 (1966).
   PubMedGoogle Scholar
• McElhaney JE, Meneilly GS, Lechelt KE, Beattie BL, Bleackley RC. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine11, 1055–1060 (1993).
   PubMedGoogle Scholar
• Webster RG. Original antigenic sin in ferrets: the response to sequential infection with influenza viruses. J. Immunol.97, 177–183 (1966).
   PubMed Web of Science ®Google Scholar
• Powers DC, Beishe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis.167, 584–592 (1993).
   PubMed Web of Science ®Google Scholar
• Krakauer T, Russo C. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacol. Immunotoxicol.23, 35–41 (2001).
   PubMed Web of Science ®Google Scholar
• Candore G, Balisteri CR, Listi F et al. Immunogenetics, gender, and longevity. Ann. NY Acad. Sci.1089, 516–537 (2006).
   PubMed Web of Science ®Google Scholar
• Mitchell BD, Hsueh WC, King TM et al. Heritability of life span in the Old Order Amish. Am. J. Med. Genet.102, 346–352 (2001).
   PubMed Web of Science ®Google Scholar
• Mocchegiani E, Costarelli L, Giacconi R et al. Nutrient–gene interaction in ageing and successful ageing: a single nutrient (zinc) and some target genes related to inflammatory/immune response. Mech. Ageing Dev.127, 517–525 (2006).
   PubMed Web of Science ®Google Scholar
• Franceschi C, Bonafe M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci.908, 244–254 (2000).
   PubMed Web of Science ®Google Scholar
• Troen BR. The biology of aging. Mt Sinai. J. Med.70(1), 3–22 (2003).
   PubMed Web of Science ®Google Scholar
• Vasto S, Candore G, Balistreri CR et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev.128, 83–91 (2007).
   PubMed Web of Science ®Google Scholar